MX2007009540A - Una solucion de cierre de cateter que comprende citrato y un parabeno. - Google Patents

Una solucion de cierre de cateter que comprende citrato y un parabeno.

Info

Publication number
MX2007009540A
MX2007009540A MX2007009540A MX2007009540A MX2007009540A MX 2007009540 A MX2007009540 A MX 2007009540A MX 2007009540 A MX2007009540 A MX 2007009540A MX 2007009540 A MX2007009540 A MX 2007009540A MX 2007009540 A MX2007009540 A MX 2007009540A
Authority
MX
Mexico
Prior art keywords
paraben
lock solution
citrate
solution
catheter
Prior art date
Application number
MX2007009540A
Other languages
English (en)
Inventor
Stephen Ash
Janusz Steczko
Gary L Swanson
Original Assignee
Ash Access Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ash Access Technology Inc filed Critical Ash Access Technology Inc
Publication of MX2007009540A publication Critical patent/MX2007009540A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/10—Aromatic or araliphatic carboxylic acids, or thio analogues thereof; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
    • A01N37/04—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof polybasic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents

Abstract

Esta invencion se relaciona con composiciones, metodos, dispositivos y equipos que se relacionan con la Infusion de una Solucion de cierre de cateter dentro de un cateter permanente. Las composiciones, metodos, dispositivos y equipos inventivos ayudan a disminuir los efectos de la invencion microbiana en cateteres y la oclusion de los cateteres. Una Solucion de cierre proporcionada por la invencion incluye citrato y un parabeno. La Solucion de preferencia tiene una densidad adecuada para la retencion de la Solucion en un cateter durante el periodo de cierre. Otra Solucion de cierre proporcionada por la invencion incluye citrato, un parabeno y un fotooxidante, tal como, por ejemplo, azul de metileno.
MX2007009540A 2005-02-08 2006-02-02 Una solucion de cierre de cateter que comprende citrato y un parabeno. MX2007009540A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/053,130 US7749529B2 (en) 2005-02-08 2005-02-08 Catheter lock solution comprising citrate and a paraben
PCT/US2006/003971 WO2006086250A2 (en) 2005-02-08 2006-02-02 A catheter lock solution comprising citrate and a paraben

Publications (1)

Publication Number Publication Date
MX2007009540A true MX2007009540A (es) 2008-02-21

Family

ID=36563297

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007009540A MX2007009540A (es) 2005-02-08 2006-02-02 Una solucion de cierre de cateter que comprende citrato y un parabeno.

Country Status (22)

Country Link
US (4) US7749529B2 (es)
EP (1) EP1688154B1 (es)
JP (1) JP5101019B2 (es)
KR (1) KR101337312B1 (es)
CN (1) CN101442956B (es)
AT (1) ATE453415T1 (es)
AU (1) AU2006212946B2 (es)
BR (1) BRPI0606969A2 (es)
CA (1) CA2597055C (es)
CL (1) CL2007002304A1 (es)
DE (1) DE602006011376D1 (es)
DK (1) DK1688154T3 (es)
ES (1) ES2337821T3 (es)
HK (1) HK1094323A1 (es)
IL (1) IL185120A (es)
MX (1) MX2007009540A (es)
PL (1) PL1688154T3 (es)
PT (1) PT1688154E (es)
RU (1) RU2399375C2 (es)
SI (1) SI1688154T1 (es)
WO (1) WO2006086250A2 (es)
ZA (1) ZA200707348B (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040092890A1 (en) * 2001-05-10 2004-05-13 Ash Stephen R. Catheter lock solution including a photo-oxidant
US20030206906A1 (en) 2001-11-26 2003-11-06 Genentech, Inc. Catheter composition and uses thereof
DE10261241A1 (de) * 2002-12-20 2004-07-15 3M Espe Ag Dentalmaterial mit bakteriostatischen und/oder bakteriziden Substanzen
US20040122126A1 (en) * 2002-12-20 2004-06-24 Dong Wu Free-radical initiator systems containing enzymes, compositions, and methods
US20040120901A1 (en) * 2002-12-20 2004-06-24 Dong Wu Dental compositions including enzymes and methods
US7749529B2 (en) * 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
US8864730B2 (en) 2005-04-12 2014-10-21 Rochester Medical Corporation Silicone rubber male external catheter with absorbent and adhesive
EP1787627A1 (en) * 2005-11-17 2007-05-23 3M Innovative Properties Company Anti-microbial dental impression material
US8167847B2 (en) 2006-06-22 2012-05-01 Excelsior Medical Corporation Antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly
EP2086571A2 (en) * 2006-11-07 2009-08-12 Genentech, Inc. Tissue plasminogen activator variant uses
CN101601084B (zh) * 2007-01-29 2011-09-07 三菱电机株式会社 图像显示装置以及图像显示方法
US20080279907A1 (en) * 2007-05-10 2008-11-13 Ash Access Technology, Inc. Antimicrobial medical devices and methods for making and using same
JP5417691B2 (ja) * 2007-07-19 2014-02-19 株式会社ジェイ・エム・エス 弱酸を含有する血管内留置カテーテルのロック溶液
US8389583B2 (en) 2008-05-23 2013-03-05 Zurex Pharma, Inc. Antimicrobial compositions and methods of use
EP2352541A4 (en) * 2008-11-12 2014-01-08 Douglas D Cary CATHETER LOCK COMPOSITION
CA2745101A1 (en) 2008-12-05 2010-06-10 Jms Co., Ltd Intravascular indwelling catheter lock solution containing weak acid and container containing the same
WO2010088192A1 (en) 2009-01-27 2010-08-05 Telelflex Medical Incorporated Bacteriostatic catheter lock containing glycerol
JP5412857B2 (ja) * 2009-02-03 2014-02-12 株式会社ジェイ・エム・エス 静菌効果を有するカテーテルロック液と該カテーテルロック液の調製方法
US9248093B2 (en) * 2009-06-11 2016-02-02 Becton, Dickinson And Company Catheter locking solution having antimicrobial and anticoagulation properties
US20110213025A1 (en) * 2009-08-10 2011-09-01 Proviflo, Llc Catheter Lock Solutions Utilizing Tocopherol and Mid-Chain Fatty Acids
DE102009037492A1 (de) 2009-08-13 2011-06-30 Affeld, Klaus, Prof. Dr.-Ing., 10629 Zentralvenöser Katheter
CA2781550C (en) * 2009-11-17 2018-01-23 Michael Anthony Folan Antimicrobial compositions containing free fatty acids
ES2569085T3 (es) 2009-11-24 2016-05-06 Fresenius Medical Care Deutschland Gmbh Composición de desinfectante
US9707375B2 (en) 2011-03-14 2017-07-18 Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. Catheter grip and method
WO2012166655A1 (en) * 2011-05-27 2012-12-06 Zurex PharmAgra, Inc. Method of treating a mammalian teat and related compositions
WO2013049033A1 (en) * 2011-09-26 2013-04-04 Cary Douglas D Bladder catheter irrigation method and composition
US20130150828A1 (en) * 2011-12-08 2013-06-13 Rochester Medical Corporation Antifungal catheter
WO2014004498A1 (en) * 2012-06-25 2014-01-03 Medical Components, Inc. Citrate anticoagulant underloaded syringe for catheter locking
US10092728B2 (en) 2012-11-20 2018-10-09 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Sheath for securing urinary catheter
US9872969B2 (en) 2012-11-20 2018-01-23 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Catheter in bag without additional packaging
US9750928B2 (en) 2013-02-13 2017-09-05 Becton, Dickinson And Company Blood control IV catheter with stationary septum activator
US9695323B2 (en) 2013-02-13 2017-07-04 Becton, Dickinson And Company UV curable solventless antimicrobial compositions
CN103357105A (zh) * 2013-07-24 2013-10-23 王亮 限制接触型侧球囊双孔导尿管
JP2014024870A (ja) * 2013-11-06 2014-02-06 Jms Co Ltd 静菌効果を有するカテーテルロック液と該カテーテルロック液の調製方法
WO2015077798A1 (en) * 2013-11-25 2015-05-28 Excelsior Medical Corporation Catheter lock solution formulations
US9675793B2 (en) 2014-04-23 2017-06-13 Becton, Dickinson And Company Catheter tubing with extraluminal antimicrobial coating
US10376686B2 (en) 2014-04-23 2019-08-13 Becton, Dickinson And Company Antimicrobial caps for medical connectors
US9789279B2 (en) 2014-04-23 2017-10-17 Becton, Dickinson And Company Antimicrobial obturator for use with vascular access devices
US10232088B2 (en) 2014-07-08 2019-03-19 Becton, Dickinson And Company Antimicrobial coating forming kink resistant feature on a vascular access device
WO2016033234A1 (en) 2014-08-26 2016-03-03 C.R. Bard, Inc Urinary catheter
US10456570B2 (en) 2015-06-11 2019-10-29 Proviflo, Llc Graft-port hemodialysis systems, devices, and methods
US10493244B2 (en) 2015-10-28 2019-12-03 Becton, Dickinson And Company Extension tubing strain relief
KR20180079398A (ko) * 2015-11-05 2018-07-10 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 증강된 안정성을 갖는 항균 용액
ES2936820T3 (es) * 2016-02-12 2023-03-22 Medical Components Inc Solución de bloqueo de catéter y terapia de bloqueo de catéter
CN106075718A (zh) * 2016-06-17 2016-11-09 北京远方通达医药技术有限公司 一种含有枸橼酸盐的封管器
WO2018009244A1 (en) * 2016-07-08 2018-01-11 Hamad Medical Corporation Endotracheal tube system
JP7012950B2 (ja) * 2016-11-17 2022-01-31 地方独立行政法人東京都立産業技術研究センター 生体組織孔閉鎖用、潰瘍保護用及び血管塞栓療術用ゾル
US10173035B2 (en) 2016-12-27 2019-01-08 Vasonics, Llc Catheter housing
CA3070865A1 (en) 2017-09-19 2019-03-28 C.R. Bard, Inc. Urinary catheter bridging device, systems and methods thereof
CN111278476B (zh) * 2017-09-22 2023-01-17 贝克顿·迪金森公司 用作导管封管液的4％柠檬酸三钠溶液
US11744983B2 (en) * 2017-11-25 2023-09-05 Hemocleanse Technologies Llc Catheter lock solution comprising sodium citrate and benzyl alcohol
CN108578792A (zh) * 2018-05-17 2018-09-28 北京康博特森科技有限公司 一种抗凝剂及其应用
RU2765741C1 (ru) * 2021-02-26 2022-02-02 Общество с ограниченной ответственностью "Многопрофильный ветеринарный центр "Пёс и Кот" (ООО МВЦ "Пёс и Кот") Способ гемодиализа у собак весом 8 и более кг

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225254A (en) * 1977-03-17 1980-09-30 Holberg Steven E Surgical scrub system
US4187719A (en) 1977-08-11 1980-02-12 B. Braun Melsungen Aktiengesellschaft Apparatus to determine the sedimentation rate of red blood cells
US4193980A (en) 1978-01-05 1980-03-18 Corning Glass Works Dry preparation for reticulocyte staining
US4225669A (en) 1979-04-27 1980-09-30 Melnick Joseph L Staining and analysis of bacteria
US4364929A (en) 1979-04-02 1982-12-21 The Purdue Frederick Company Germicidal colloidal lubricating gels and method of producing the same
US4885855A (en) 1982-09-29 1989-12-12 Fearing Manufacturing Co., Inc. Antibacterial attachment
US5088996A (en) 1984-04-16 1992-02-18 Kopfer Rudolph J Anti-aerosoling drug reconstitution device
US4677143A (en) 1984-10-01 1987-06-30 Baxter Travenol Laboratories, Inc. Antimicrobial compositions
DE3622089A1 (de) * 1986-07-02 1988-01-07 Krueger Gmbh & Co Kg Viruzides mittel mit breitbandwirkung
US4929242A (en) 1986-11-26 1990-05-29 Baxter International Inc. Solution and method for maintaining patency of a catheter
US4853227A (en) 1987-10-23 1989-08-01 Ciba-Geigy Corporation Transdermal administration of a systemic active agent to a premature neonatal infant
DE3812524A1 (de) 1988-04-15 1989-10-26 Fresenius Ag Dialysier- und spuelloesung fuer die intraperitoneale verabreichung mit antimikrobieller ausruestung
US5571666A (en) 1988-10-28 1996-11-05 Oklahoma Medical Research Foundation Thiazine dyes used to inactivate HIV in biological fluids
US4950665A (en) 1988-10-28 1990-08-21 Oklahoma Medical Research Foundation Phototherapy using methylene blue
CA2003856C (en) 1988-11-25 1996-01-30 Toshio Satoh Therapeutic agent for renal disorders
DK708488D0 (da) 1988-12-20 1988-12-20 Nordisk Gentofte Faktor i praeparat
US5002965A (en) 1989-05-09 1991-03-26 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Use of ginkgolides to prevent reperfusion injury in organ transplantation
US5032615A (en) 1989-10-31 1991-07-16 The Regents Of The University Of California Continuous hemodialysis using citrate
US4973328A (en) 1989-11-20 1990-11-27 Gerard Smith Closed system administering assembly
US5103817A (en) 1990-07-20 1992-04-14 Xomed-Treace Inc. Automatic dye dispersant for endotracheal tubes and catheters
US5624414A (en) 1992-02-18 1997-04-29 St. Francis Research Institute Needleless straight infusion port
US5647855A (en) 1992-05-06 1997-07-15 Trooskin; Stanley Z. Self-healing diaphragm in a subcutaneous infusion port
US5378227A (en) 1992-08-11 1995-01-03 Cobe Laboratories, Inc. Biological/pharmaceutical method and apparatus for collecting and mixing fluids
US6207107B1 (en) 1992-10-05 2001-03-27 Baxter International Inc. Steam sterilizable system for inactivating viral contaminants in body fluids
US5436007A (en) 1992-10-23 1995-07-25 Abbott Laboratories Diaper rash lotion
US5688516A (en) 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
US6034133A (en) * 1993-11-05 2000-03-07 The University Of Virginia Patents Foundation Use of a virucidal hand lotion to prevent the spread of rhinovirus colds
US8241259B2 (en) * 1994-06-14 2012-08-14 Innovation Technologies, Inc. Wound irrigation device and method
SI9400289A (en) 1994-07-13 1996-02-29 Ponikvar Jadranka Buturovic A method for preventing blood coagulation in a haemodialysis circuit or haemodialysis analogy procedure in the extra-body circuit.
US6239048B1 (en) * 1994-12-28 2001-05-29 Fibermark, Inc. Light-activated antimicrobial and antiviral materials
US5624704A (en) 1995-04-24 1997-04-29 Baylor College Of Medicine Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent
US6025312A (en) 1995-06-30 2000-02-15 P & Pf Co., Ltd. Antibacterial, bactericidal and antiseptic agent, dermatologic preparation and detergent composition
US5709672A (en) 1995-11-01 1998-01-20 Texas Tech University Health Sciences Center Silastic and polymer-based catheters with improved antimicrobial/antifungal properties
US5843016A (en) 1996-03-18 1998-12-01 Physion S.R.L. Electromotive drug administration for treatment of acute urinary outflow obstruction
DE19612057A1 (de) * 1996-03-27 1997-10-02 Antiseptica Chem Pharm Prod Gm Händedesinfektionsmittel
US5858641A (en) 1996-09-17 1999-01-12 Shanbrom Technologies, Llc Disinfectant dye removal from blood and blood fractions using a porous poly(vinyl alcohol-acetal) copolymer
GB9626795D0 (en) 1996-12-23 1997-02-12 Geistlich Soehne Ag Combating infection in delivery systems
US5811741A (en) 1997-03-19 1998-09-22 Coast Machinery, Inc. Apparatus for placing geophones beneath the surface of the earth
US6488665B1 (en) * 1997-04-08 2002-12-03 Allegiance Corporation Antimicrobial alcohol gel pre-operative skin-preparation delivery system
US5811471A (en) 1997-09-15 1998-09-22 Shanbrom Technologies Llc Disinfectant plastic sponge material
US6361786B1 (en) 1997-09-15 2002-03-26 Shanbrom Technologies Microbicide treated polymeric materials
US6022551A (en) * 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
US6361524B1 (en) 1998-04-14 2002-03-26 Becton, Dickinson And Company Syringe assembly
US6150366A (en) * 1998-06-15 2000-11-21 Pfizer Inc. Ziprasidone formulations
US6166007A (en) 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6958049B1 (en) * 1998-08-25 2005-10-25 Ash Access Technology, Inc. Method of enhancing catheter patency using a citrate salt catheter lock solution
PT1107807E (pt) 1998-08-25 2007-01-31 Ash Access Technology Inc Uso de um sal citrato numa solução de enchimento de cateter
US6190371B1 (en) 1999-01-15 2001-02-20 Maginot Vascular Systems Catheter system having retractable working catheter and associated method
CN1086592C (zh) * 1999-02-12 2002-06-26 中国人民解放军第四五五医院 抗菌抗凝硅胶导管
US6423329B1 (en) * 1999-02-12 2002-07-23 The Procter & Gamble Company Skin sanitizing compositions
US6187768B1 (en) 1999-06-01 2001-02-13 Becton, Dickinson And Company Kit for flushing medical devices and method of preparation
US6685694B2 (en) 1999-07-23 2004-02-03 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6592564B2 (en) 1999-07-23 2003-07-15 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6679870B1 (en) 1999-07-23 2004-01-20 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
WO2001024825A2 (en) 1999-10-01 2001-04-12 The General Hospital Corporation Doing Business As Massachusetts General Hospital Significance of dosimetry in photodynamic therapy of injured arteries
US6350251B1 (en) 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
PT1284780E (pt) 2000-05-10 2008-08-18 Ash Access Technology Inc Uma solução de controlo de cateter incluindo um fotooxidante
WO2001089513A1 (en) 2000-05-24 2001-11-29 Uab Research Foundation Use of citrate-containing dialysate for renal dialysis treatment
US6423050B1 (en) 2000-06-16 2002-07-23 Zbylut J. Twardowski Method and apparatus for locking of central-vein catheters
US6451003B1 (en) 2000-08-16 2002-09-17 Biolink Corporation Method and apparatus for overcoming infection in a tissue pocket surrounding an implanted device
US6881731B1 (en) 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
US7713472B2 (en) 2001-01-12 2010-05-11 Board Of Regents, The University Of Texas System Antiseptic derivatives with broad spectrum antimicrobial activity for the impregnation of surfaces
US7399790B2 (en) * 2001-02-28 2008-07-15 Konowalchuk Thomas W Virucidal compositions
ATE322274T1 (de) 2001-04-23 2006-04-15 Nucryst Pharm Corp Arzneimittel oder pflaster enthaltend ein metall wie silber gold, platin oder palladium als antimikrobiellen wirkstoff und dessen verwendung in der behandlung von hautentzündungen
US20040092890A1 (en) 2001-05-10 2004-05-13 Ash Stephen R. Catheter lock solution including a photo-oxidant
US20050215978A1 (en) 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
US6909030B2 (en) 2001-10-15 2005-06-21 Cedars-Sinai Medical Center PTTG knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes
DE60321773D1 (de) 2002-03-14 2008-08-07 Ash Access Technology Inc Medizinische vorrichtungen mit antibakteriellen eigenschaften
CN1301110C (zh) * 2002-04-01 2007-02-21 Nd合伙人股份有限公司 包含牛磺酰胺衍生物及羧酸和/或其盐的抗微生物闭锁
CN100430105C (zh) * 2002-04-01 2008-11-05 Nd合伙人股份有限公司 克服植入器具周围的组织袋中的感染的装置
US6962714B2 (en) * 2002-08-06 2005-11-08 Ecolab, Inc. Critical fluid antimicrobial compositions and their use and generation
US20040219179A1 (en) * 2002-09-20 2004-11-04 Mcdaniel David H. Skin abrasive agents
CA2515657C (en) * 2003-02-11 2015-06-23 Dilip Tapadiya, M.D., Inc. Wound irrigation equipment
US6729786B1 (en) * 2003-03-14 2004-05-04 Mediflex Hospital Products, Inc. Liquid applicator for coloring a liquid
BRPI0409752A (pt) * 2003-04-16 2006-05-09 Neochemical Desarrollos Avanza uso de um peróxido de dialquil cetona como um biocida: agente esterilizante, anti-séptico, desinfetante e anti-parasìtico e método de esterilização, desinfecção, assepsia ou eliminação de parasitas
US7601731B2 (en) 2003-06-06 2009-10-13 Board Of Regents, The University Of Texas System Antimicrobial flush solutions
US20050084471A1 (en) * 2003-09-09 2005-04-21 3M Innovative Properties Company Concentrated antimicrobial compositions and methods
US20050197364A1 (en) 2003-10-07 2005-09-08 Kelly Michael G. Amide compounds as ion channel ligands and uses thereof
US20050197634A1 (en) * 2004-01-20 2005-09-08 Board Of Regents, The University Of Texas System Methods for coating and impregnating medical devices with antiseptic compositions
US7784424B2 (en) * 2004-11-22 2010-08-31 Belanger Industrial Products, Inc. Heated towel dispenser
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
US20060204466A1 (en) * 2005-03-08 2006-09-14 Ecolab Inc. Hydroalcoholic antimicrobial composition with skin health benefits
US20060264423A1 (en) * 2005-05-20 2006-11-23 Bioenvision, Inc. Methylene Blue Therapy of Viral Disease
WO2007038201A1 (en) * 2005-09-23 2007-04-05 Bioenvision, Inc. Methylene blue therapy of parasitic infections
US9629361B2 (en) * 2006-02-09 2017-04-25 Gojo Industries, Inc. Composition and method for pre-surgical skin disinfection
EP3085683B1 (en) * 2006-02-10 2020-04-29 DuPont Tate & Lyle Bio Products Company, LLC Composition comprising an extract and bio-derived 1,3-propanediol as non irritating solvent
AU2007214450B2 (en) * 2006-02-14 2011-08-04 Care Fusion 2200, Inc Liquid applicator and method for reducing the concentration of by-products from antiseptic
WO2008019083A2 (en) 2006-08-04 2008-02-14 Ash Access Technology, Inc. Antimicrobial therapy for indwelling catheters and for sanitizing surfaces
US20080279907A1 (en) * 2007-05-10 2008-11-13 Ash Access Technology, Inc. Antimicrobial medical devices and methods for making and using same
US8389583B2 (en) * 2008-05-23 2013-03-05 Zurex Pharma, Inc. Antimicrobial compositions and methods of use

Also Published As

Publication number Publication date
ZA200707348B (en) 2008-12-31
SI1688154T1 (sl) 2010-05-31
CN101442956A (zh) 2009-05-27
ES2337821T3 (es) 2010-04-29
EP1688154A1 (en) 2006-08-09
AU2006212946B2 (en) 2012-06-28
JP5101019B2 (ja) 2012-12-19
KR20070114737A (ko) 2007-12-04
US20100240750A1 (en) 2010-09-23
EP1688154B1 (en) 2009-12-30
IL185120A (en) 2014-06-30
RU2007133649A (ru) 2009-03-20
ATE453415T1 (de) 2010-01-15
HK1094323A1 (en) 2007-03-30
IL185120A0 (en) 2008-01-20
US7749529B2 (en) 2010-07-06
CA2597055A1 (en) 2006-08-17
WO2006086250A3 (en) 2007-11-15
CL2007002304A1 (es) 2008-06-06
PT1688154E (pt) 2010-03-26
JP2006232829A (ja) 2006-09-07
CN101442956B (zh) 2014-05-07
US20060177477A1 (en) 2006-08-10
US9011897B2 (en) 2015-04-21
US20130178526A1 (en) 2013-07-11
PL1688154T3 (pl) 2010-06-30
DK1688154T3 (da) 2010-05-03
AU2006212946A1 (en) 2006-08-17
WO2006086250A2 (en) 2006-08-17
US8226971B2 (en) 2012-07-24
CA2597055C (en) 2013-10-15
US20120277314A1 (en) 2012-11-01
KR101337312B1 (ko) 2013-12-06
DE602006011376D1 (de) 2010-02-11
BRPI0606969A2 (pt) 2009-07-28
RU2399375C2 (ru) 2010-09-20

Similar Documents

Publication Publication Date Title
MX2007009540A (es) Una solucion de cierre de cateter que comprende citrato y un parabeno.
WO2008019083A3 (en) Antimicrobial therapy for indwelling catheters and for sanitizing surfaces
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
WO2006012527A8 (en) Bivalent linkers and conjugates thereof
EP2260835A3 (en) Composition for proteasome inhibition
WO2006063176A3 (en) Inhibition of biofilm formation using bacteriophage
NZ606825A (en) Methods and compositions for treating complement-associated disorders
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
WO2008092006A3 (en) Antimicrobial compositions
WO2008060380A3 (en) Anti-infective alcohol catheter solution with chlorhexidine treated catheter
AU2001263044A1 (en) A catheter lock solution including a photo-oxidant
ATE495735T1 (de) Verfahren und zusammensetzung, die immunomodulatorische verbindungen zur behandlung von mit niedrigen plasmaleptin-spiegeln in zusammenhang stehenden störungen verwenden
WO2008005651A3 (en) Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis
CA2518971A1 (en) Composition for administration of iron for the treatment of restless legs syndrome
WO2010110908A3 (en) Transdermal venous access locking solution
WO2008059041A3 (en) Complementation of factor xi deficiency by factor v mutants
WO2008005059A3 (en) Treatment of mouth and urinary tract infections
NZ621994A (en) Transdermal venous access locking solutions
MX2007005314A (es) Cetoles espirociclicos y su uso.
WO2008001278A3 (en) Extracts of plectranthus hadiensis, argenatus or myrianthus for the treatment of microbial infection
WO2006124358A3 (en) Method of treating a coccidioides infection by administering an ambruticin compound
TW200613069A (en) Washing method
UA102145C2 (ru) Иммуногенная композиция, которая содержит lawsonia intracellularis
UA86813C2 (ru) Ингибиторы бета-гидроксистероидной дегидрогеназы типа 1

Legal Events

Date Code Title Description
FG Grant or registration